NIH-backed research reveals that a simple skin test may revolutionize early diagnosis of Parkinson’s and related neurodegenerative disorders.
NIH-backed research reveals that a simple skin test may revolutionize early diagnosis of Parkinson’s and related neurodegenerative disorders.
The bispecific antibody earns full approval after demonstrating durable responses in heavily pre-treated patients.
A new framework aims to harmonize clinical trial data reporting across borders, boosting transparency and accelerating global drug …
FDA mandates clearer drug ads, Merck expands oncology portfolio, and political shifts raise questions about public health leadership.
The CGM giant and smart ring innovator join forces to integrate biosensor data and reshape personal health tracking.
Amgen’s MariTide leads the pack, while other candidates face setbacks in the competitive GLP-1RA landscape.
Memorial Sloan Kettering researchers uncover how pancreatic cancer cells suppress immune triggers by manipulating genetic elements.
A new research center and FDA-backed diversity mandates aim to reshape clinical trial equity and representation across the …
AbbVie’s Emraclidine Misses Mark in Schizophrenia Trials—But Safety Signals Keep Hope Alive
Novo Nordisk’s oral obesity drug shows superior efficacy over Eli Lilly’s candidate, reshaping the competitive landscape in metabolic …
Already a subscriber? Log in